Condition: Lung Cancer · Sponsor: University of Illinois at Chicago
This is a two-cohort (screen naïve vs screen established), prospective, longitudinal, single-center clinical study design that will provide data to comprehensively evaluate patient-reported outcomes of Artificial Intelligence (AI) based prediction of an individual's risk of developing lung cancer over the next 3 years.
This description comes directly from the study's public registry record.
Ameen Salahudeen, MD, PhD · (312) 355-1625 · ameen@uic.edu
Erica Seltzer, DrPh, MPH · (312) 413-7432 · eseltzer@uic.edu
Always discuss trial participation with your own doctor first.
| University of Illinois at Chicago | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07458425